FDA-cleared profile

Critical Care Suite with Enteric Tube Positioning AI Algorithm

Ge Medical Systems, LLC · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.

Clinical role
Detection/localization and immediate visualization/notification support; no quantification is provided
Images and patients
X-ray/Radiography · Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
Key limitation
Keep in mind: Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi Input: Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.
  • Who uses it?Intended users: Licensed qualified healthcare professionals trained to independently place or assess enteric tubes inserted nasally or orally, and radiologists
  • What does the software produce?Output: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
  • What is its most important limitation?Key limitation: Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.

Clinical takeaway. Clinical role: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.

Evidence takeaway. Evidence from the reviewed source record: The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Detection/localization and immediate visualization/notification support; no quantification is provided
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Critical-care/acute-care imaging workflow, including mobile X-ray use for patients with limited mobility; indicated for adult and pediatric patients
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Licensed qualified healthcare professionals trained to independently place or assess enteric tubes inserted nasally or orally, and radiologists
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
enteric tube detection: 99.2% (95% CI: 98.2%, 99.7%) ; tube tip detection: 95.7% (95% CI: 93.5%, 97.3%); side port detection: 93.1% (95% CI: 90.4%, 95.2%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
enteric tube detection: 97.5% (95% CI: 94.7%, 99.1%) ; tube tip detection: 94.1% (95% CI: 90.1%, 96.8%); side port detection: 85.9% (95% CI: 80.1%, 90.5%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Critical Care Suite with Enteric Tube Positioning AI Algorithm regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult and Pediatric
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K253502
  • Samplen=954
  • Sites5
  • IndependenceIndependence not established

K253502

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K253502. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K253502: Critical Care Suite with Enteric Tube Positioning AI Algorithm

  2. Routing

    Source context, not route validation: The software module can be deployed on PACS, on-premise, on-cloud, or digital projection radiographic systems; AMX Navigate mobile X-ray was the initial deployment platform. Results are sent as a secondary DICOM image and DICOM tag to a PACS, image-storage system, X-ray system, or other DICOM destination.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K253502: Critical Care Suite with Enteric Tube Positioning AI Algorithm

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-08 ·

  4. Returned objects

    Source context, not route validation: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K253502: Critical Care Suite with Enteric Tube Positioning AI Algorithm

  5. Viewer/worklist/report

    Unresolved route: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K253502: Critical Care Suite with Enteric Tube Positioning AI Algorithm

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Integration
The software module can be deployed on PACS, on-premise, on-cloud, or digital projection radiographic systems; AMX Navigate mobile X-ray was the initial deployment platform. Results are sent as a secondary DICOM image and DICOM tag to a PACS, image-storage system, X-ray system, or other DICOM destination.
  • Exact FDA submission
  • Checked 2026-09-08
Security
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.

Monitoring
GE HealthCare's product security page states that it provides a credentialed Product Security Portal offering security updates, vulnerability status and actions, and patch views for GE HealthCare products under its Cybersecurity Risk Management System, and links its Coordinated Vulnerability Disclosure Statement.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names GE HealthCare generally and does not scope these commitments to any specific product release; exact-release scope is not established. Portal access is credentialed; contents were not read.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Critical Care Suite with Enteric Tube Positioning AI Algorithm; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253502
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-04-14
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K253502 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Deployment: Not verified - checked 2026-09-08 - Exact FDA submission

    The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K253502: Critical Care Suite with Enteric Tube Positioning AI Algorithm

    U.S. Food and Drug Administration - Published 2026-04-14 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Critical Care Suite with Enteric Tube Positioning AI Algorithm model card (K253502)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K253502

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  8. GE HealthCare: Product Security (portal and Cybersecurity Risk Management System)

    GE HealthCare - Accessed 2026-10-26

    Scope: security

Research history

  1. K253502 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07
FDA-cleared K250753

VELMENI for DENTISTS (V4D)

Velmeni Inc.

Authorized purpose: Assists dentists in detecting caries, fillings/restorations, fixed prostheses, and implants on digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients aged 15 years and older; final diagnoses and treatment plans remain the dentist's responsibility.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-09-02

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history